Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

Delayed Data
As of 4:00pm ET
 -2.37 / -10.75%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 16.00, with a high estimate of 35.00 and a low estimate of 7.00. The median estimate represents a -18.70% decrease from the last price of 19.68.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Hold stock in Valeant Pharmaceuticals. This rating has held steady since December, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.24%
Growthannually -30.79%


Growthquarterly -2.83%
Growthannually -9.92%
Key to the earnings and sales forecast charts.